EQS: latest releases

News releases provided by EQS Group AG EQS Group AG.

DGAP-News: 4SC AG provides results for financial year 2019 and outlook

Wednesday, March 25, 2020 - 7:00am

Planegg-Martinsried, Germany, 25 March 2020 - 4SC AG (4SC, FSE Prime Standard: VSC) today published the financial results for the financial year ended 31 December 2019, presenting all material reporting period developments and provides an outlook for 2020.

Key Points: 
  • Planegg-Martinsried, Germany, 25 March 2020 - 4SC AG (4SC, FSE Prime Standard: VSC) today published the financial results for the financial year ended 31 December 2019, presenting all material reporting period developments and provides an outlook for 2020.
  • As of 31 December 2019, 4SC holds cash balance/funds of 45,765 thousand (31 December 2018: 25,036 thousand).
  • For 2020, 4SC is expecting an average monthly use of cash from operations of between 2,200 thousand and 2,600 thousand.
  • 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs.

DGAP-News: Goldsource Closes $6.6 Million Brokered Private Placement, 80% of Over-Allotment Option Exercised

Tuesday, March 24, 2020 - 9:04pm

Goldsource Closes $6.6 Million Brokered Private Placement, 80% of Over-Allotment Option Exercised

Key Points: 
  • Goldsource Closes $6.6 Million Brokered Private Placement, 80% of Over-Allotment Option Exercised
    The issuer is solely responsible for the content of this announcement.
  • Each Unit consisted of one common share of Goldsource ("Common Share") and one-half of one Common Share purchase warrant (each whole warrant, a "Warrant").
  • Each Warrant entitles the holder to acquire one Common Share at an exercise price of $0.16 until September 24, 2022.
  • The completed Offering includes exercise of the agents' over-allotment option for $1,602,909, representing approximately 80% of the over-allotment option to purchase additional Units at $0.11 per Unit.

LYXOR ETF - Important Information - ETF Liquidation 27/03/2020 - Lyxor J.P. Morgan Multi-Factor World Index UCITS ETF

Tuesday, March 24, 2020 - 7:02pm

Please note that any fees or costs incurred within the context of the liquidation will be borne by the Sub-Fund.

Key Points: 
  • Please note that any fees or costs incurred within the context of the liquidation will be borne by the Sub-Fund.
  • Further to the above, the Board has decided to suspend the Subscription and the Redemption of Shares on the primary market within the Sub-Fund as from March 25, 2020.
  • Any liquidation proceeds which cannot be distributed to Shareholders will be deposited on their behalf with the Caisse de Consignation in Luxembourg.
  • For any questions, do not hesitate to contact Lyxor Client Services at the following contact details: Phone number +33 1 42 13 42 14 - Email address: client-services-etf@lyxor.com.

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

Tuesday, March 24, 2020 - 2:04pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

DGAP-News: LeadsRx Expands International Business with First Reseller - Brazil-based Puzzle Ads

Tuesday, March 24, 2020 - 1:14pm

PORTLAND, ORand FLORIANPOLIS, BRAZIL / ACCESSWIRE /March 24, 2020 / LeadsRx, a marketing attribution software company, has expanded internationally with its first reseller, Puzzle Ads.

Key Points: 
  • PORTLAND, ORand FLORIANPOLIS, BRAZIL / ACCESSWIRE /March 24, 2020 / LeadsRx, a marketing attribution software company, has expanded internationally with its first reseller, Puzzle Ads.
  • Puzzle Ads is the first vendor to offer LeadsRx impartial multi-touch attribution to marketers and advertisers in Brazil.
  • "LeadsRx marketing attribution technology is unrivaled in the industry," said, Ins Pimpo, Operations Manager of Puzzle Ads.
  • "Puzzle Ads is ahead of the curve, realizing the vast potential that marketing attribution holds for advertisers," says AJ Brown, CEO and cofounder of LeadsRx.

PJSC Magnit notifies on the transactions by persons discharging managerial responsibilities and persons closely associated with them

Tuesday, March 24, 2020 - 1:14pm

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • Press Release | Krasnodar | March 24, 2020
    Krasnodar, Russia (March 24, 2020): Magnit PJSC (MOEX and LSE: MGNT; Company, Group), one of Russia's leading retailers, notifies on the transactions by persons discharging managerial responsibilities and persons closely associated with them.

DGAP-News: Schaeffler AG: Schaeffler Responds to the Corona Crisis

Tuesday, March 24, 2020 - 1:14pm

Herzogenaurach | March 24, 2020 | Due to the worldwide spread of the corona crisis and the resulting measures and restrictions, the Management Board of Schaeffler AG today suspended the guidance for the 2020 financial year for the Schaeffler Group and its divisions that was published on March 10, 2020.

Key Points: 
  • Herzogenaurach | March 24, 2020 | Due to the worldwide spread of the corona crisis and the resulting measures and restrictions, the Management Board of Schaeffler AG today suspended the guidance for the 2020 financial year for the Schaeffler Group and its divisions that was published on March 10, 2020.
  • In addition to protecting the health of the company's employees, sustaining the supply chain and supporting customers are also a priority.
  • "The corona crisis is affecting all of us as well as the economy as a whole.
  • With just under 2,400 patent applications in 2019, Schaeffler is Germany's second most innovative company according to the DPMA (German Patent and Trademark Office).

Director/PDMR Shareholding

Tuesday, March 24, 2020 - 12:05pm

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • Hassan Gozal is sole shareholder and Director of Daax Corporation FZE, and is a Non-Executive Director of Genel Energy plc.
  • The notification below is made in accordance with the requirements of the EU Market Abuse Regulation provides further detail.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Monday, March 23, 2020 - 2:03pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

DGAP-News: Secarna Pharmaceuticals announces the acquisition of LNAplusTM based antisense drug candidates by Lipigon Pharmaceuticals

Monday, March 23, 2020 - 8:01am

Under this agreement, Lipigon acquires certain antisense drug candidates, which were developed with Secarna's proprietary LNAplusTM platform, including the corresponding patent portfolio.

Key Points: 
  • Under this agreement, Lipigon acquires certain antisense drug candidates, which were developed with Secarna's proprietary LNAplusTM platform, including the corresponding patent portfolio.
  • The antisense oligonucleotide candidates targeting the ANGPTL gene family for the treatment of cardiovascular and metabolic diseases were previously generated by Secarna and Lipigon under a target validation and drug discovery collaboration.
  • Going forward, Lipigon will fund and continue the development of the acquired assets and Secarna receives payments customary for such a transaction.
  • Inhibiting the ANGPTL gene family members ANGPTL3 and ANGPTL4 with Secarna's LNAplusTM based antisense oligonucleotides has shown to positively affect plasma lipid levels.

DGAP-News: Hornbach Holding AG & Co. KGaA: Hornbach increases net sales by 8.4 % to Euro 4.7 billion in 2019/20 financial year - corona crisis looms large

Friday, March 20, 2020 - 7:00am

DGAP-News: Hornbach Holding AG & Co. KGaA / Key word(s): Development of Sales

Key Points: 
  • DGAP-News: Hornbach Holding AG & Co. KGaA / Key word(s): Development of Sales
    Hornbach Holding AG & Co. KGaA: Hornbach increases net sales by 8.4 % to Euro 4.7 billion in 2019/20 financial year - corona crisis looms large
    The issuer is solely responsible for the content of this announcement.
  • Based on preliminary figures, the Hornbach Holding AG & Co. KGaA Group increased its net sales by 8.4 % to more than Euro 4.7 billion.
  • On a like-for-like basis and net of currency items, group-wide sales at the DIY stores with garden centers (DIY) grew by 7.7 %.
  • Albrecht Hornbach, CEO of Hornbach Management AG, nevertheless expects the crisis to have a noticeable impact on the 2020/21 financial year.

DGAP-News: SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2020

Thursday, March 19, 2020 - 3:02pm

SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or the "Company") has today published the agenda for the annual general meeting of shareholders of the Company (the "AGM").

Key Points: 
  • SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or the "Company") has today published the agenda for the annual general meeting of shareholders of the Company (the "AGM").
  • Based on today's risk assessment, the Company has convened the AGM and plans to hold the AGM on 30 April 2020.
  • SHOP APOTHEKE EUROPE gives top priority to the health of its employees, shareholders and other stakeholders when holding the AGM.
  • SHOP APOTHEKE EUROPE strives to take the best measures possible in view of the Covid-19 outbreak, while limiting interruption to its business (including the AGM) as much as possible.

NCSP Group's consolidated cargo turnover totaled 11.8 million tons in January 2020

Thursday, March 19, 2020 - 1:11pm

In January 2020, transshipment of liquid cargo at NCSP Group's terminals was up by 9.7% or 869 thousand tons year-over-year and amounted to 9,845 thousand tons.

Key Points: 
  • In January 2020, transshipment of liquid cargo at NCSP Group's terminals was up by 9.7% or 869 thousand tons year-over-year and amounted to 9,845 thousand tons.
  • Transshipment of crude oil reached 6,291 thousand tons (an increase of 14.3% or 789 thousand tons) and of oil products - 3,489 thousand tons (an increase of 3.2% or 108 thousand tons) against 2019.
  • In January 2020, transshipment of bulk cargo at NCSP Group's terminals increased by 48.2% or 210 thousand tons year-over-year and amounted to 644 thousand tons.
  • In January 2020, transshipment of general cargo at NCSP Group's terminals was down by 26.4% or 353 thousand tons year-over-year and amounted to 984 thousand tons.

Chelverton UK Dividend Trust plc: Holding(s) in Company

Thursday, March 19, 2020 - 10:03am

Chelverton UK Dividend Trust plc: Holding(s) in Company

Key Points: 
  • Chelverton UK Dividend Trust plc: Holding(s) in Company
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • 1a.
  • Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

DGAP-News: HELLA GmbH & Co. KGaA: Business development so far in line with expectations, but adjustment of company outlook necessary due to COVID-19 pandemic

Wednesday, March 18, 2020 - 1:08pm

HELLA GmbH & Co. KGaA: Business development so far in line with expectations, but adjustment of company outlook necessary due to COVID-19 pandemic

Key Points: 
  • HELLA GmbH & Co. KGaA: Business development so far in line with expectations, but adjustment of company outlook necessary due to COVID-19 pandemic
    The issuer is solely responsible for the content of this announcement.
  • On a provisional basis, currency and portfolio-adjusted sales decreased by 3.7 percent to 4.8 billion (previous year: 5.0 billion).
  • HELLA GmbH & Co. KGaA, Lippstadt: HELLA is a global, family-owned company, listed on the stock exchange, with over 125 locations in some 35 countries.
  • Furthermore, in its Special Applications segment, HELLA develops, manufactures and sells lighting and electronic products for specialist vehicles.

DGAP-News: VERBUND AG: annual results for 2019: VERBUND's excellent performance will strengthen its future positioning

Wednesday, March 18, 2020 - 8:00am

Important because we adopted additional key strategic objectives that will have positive effects for the future of the Group.

Key Points: 
  • Important because we adopted additional key strategic objectives that will have positive effects for the future of the Group.
  • Gratifying because we again delivered a highly respectable economic performance, which confirms our chosen strategy.
  • We firmly believe that as a utility that almost exclusively uses renewable energy sources we are ideally positioned for a decarbonised, decentralised and digitalised future of energy.
  • This in turn was rewarded by the capital market and in addition to the strong performance of VERBUND shares, which were trading 20.1% higher in 2019, resulted in two rating upgrades for VERBUND AG.

Sberbank: Sberbank holds Supervisory Board Meeting

Tuesday, March 17, 2020 - 8:02pm

March 17, 2020, Moscow- Sberbank has held a press conference dedicated to the results of a Supervisory Board meeting.

Key Points: 
  • March 17, 2020, Moscow- Sberbank has held a press conference dedicated to the results of a Supervisory Board meeting.
  • Ahead of the press conference he also participated in the online Supervisory Board meeting.
  • The Supervisory Board took a note of the Consolidated Financial Statements of Sberbank for the year 2019; Sberbank Group's risk report for 2019; Sberbank investor base and Sberbank investor perception study report in 2019 as well as an interim report on the operations of the Committee for Minority Shareholder Relations of Sberbank; the status of corporate culture development at Sberbank; and Sberbank ecosystem metrics.
  • The Supervisory Board viewed the proposals submitted by shareholders of Sberbank on the candidates to be elected to the Supervisory Board at the Annual General Meeting of Shareholders on 2019 results.

Turkiye Garanti Bankasi A.S.: Distribution Results of Bank Bonds to Qualified Investors

Tuesday, March 17, 2020 - 4:04pm

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • The issuance of the bank bonds in the nominal value of TRY 713,454,029 with a maturity of 93 days with 31 days coupon payments indexed to BIST TLREF index; to be sold to qualified investors has been realized as of (17.03.2020).

DGAP-News: Abivax 2019 Financial Results and Operations Update

Monday, March 16, 2020 - 7:01pm

The observations confirmed the preliminary positive results on safety and tolerability of ABX464 along with a first evidence of its excellent long-term efficacy.

Key Points: 
  • The observations confirmed the preliminary positive results on safety and tolerability of ABX464 along with a first evidence of its excellent long-term efficacy.
  • Based on the encouraging results from the Phase 2a induction and maintenance trials, Abivax initiated a Phase 2b study, ABX464-103, in UC and enrolled the first patient in August 2019.
  • Top line results from this trial are expected in Q4 2020.
  • Abivax is currently planning for a start of the enrollment of patients in the second half of 2020.

DGAP-News: ALX Resources Corp. Intersects Nickel-Copper Mineralization at Falcon Nickel Project, Northern Saskatchewan

Monday, March 16, 2020 - 12:04pm

ALX Resources Corp. Intersects Nickel-Copper Mineralization at Falcon Nickel Project, Northern Saskatchewan

Key Points: 
  • ALX Resources Corp. Intersects Nickel-Copper Mineralization at Falcon Nickel Project, Northern Saskatchewan
    The issuer is solely responsible for the content of this announcement.
  • Vancouver, British Columbia--(Newsfile Corp. - March 16, 2020) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce that nickel and copper mineralization has been intersected in the second hole of the 2020 drilling program at its 100%-owned Falcon Nickel Project ("Falcon", or the "Project") located in the northern Athabasca region of Saskatchewan, Canada.
  • "ALX has intersected sulphide mineralization in a new zone that was never detected by historical exploration," said Warren Stanyer, CEO and Chairman of ALX.
  • Forward-looking statements in this news release include: the Falcon Nickel Project ("Falcon") is prospective for nickel-copper-cobalt mineralization; the Company's plans to undertake exploration activities at Falcon, and expend funds on Falcon.

TUI AG: TUI AG - Temporary suspension of the vast majority of all travel operations due to COVID-19 and implications for Guidance 2020

Sunday, March 15, 2020 - 11:00pm

This temporary suspension is aimed at contributing to global governmental efforts to mitigate the effects of the spread of the COVID-19.

Key Points: 
  • This temporary suspension is aimed at contributing to global governmental efforts to mitigate the effects of the spread of the COVID-19.
  • In light of this situation, the Executive Board has decided today to withdraw the Financial Year 2020 guidance as communicated on 11 February 2020.
  • Furthermore the Executive Board also refrains from issuing a new guidance for the Financial Year 2020 under the current circumstances.
  • Moreover, we have decided to apply for state aid guarantees to support the business until normal operations are resumed.

DGAP-News: Haier Smart Home Co.,Ltd.: Haier International Co. Ltd. revised intention in relation to share purchases

Friday, March 13, 2020 - 3:02pm

The Possible Privatisation was first announced by the Company on 12 December 2019 with monthly updates having been published on 16 January 2020 and 14 February 2020.

Key Points: 
  • The Possible Privatisation was first announced by the Company on 12 December 2019 with monthly updates having been published on 16 January 2020 and 14 February 2020.
  • HIC further notified the Company that it would inform the Company once it recommences the Further Purchases as and when appropriate.
  • It was announced that HIC in total intended to purchase D-Shares for EUR 66 million, including the executed Block Trade and the intended Further Purchases.
  • 13.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Friday, March 13, 2020 - 2:02pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Thursday, March 12, 2020 - 2:04pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

EQS-News: Mobile TeleSystems PJSC: MTS Announces Q4 & FY 2019 Results

Thursday, March 12, 2020 - 12:04pm

Revenue for the quarter was up 4.1% year-over-year to reach 127.1 billion rubles, driven by core mobile connectivity in Russia, as well as a positive top-line impact from MTS Bank.

Key Points: 
  • Revenue for the quarter was up 4.1% year-over-year to reach 127.1 billion rubles, driven by core mobile connectivity in Russia, as well as a positive top-line impact from MTS Bank.
  • Group Adjusted OIBDA likewise notched up 1.0% year-over-year in Q4 to reach 51.6 billion rubles.
  • Altogether, in 2019 we maintained steady growth and delivered on our full-year financial targets when adjusting for the sale of our Ukraine operations.
  • Going forward, our strategic imperatives are clear: maintain leadership in mobile connectivity, while pursuing new growth opportunities in digital products and services.

Sberbank: Persons Discharging Managerial Responsibilities

Wednesday, March 11, 2020 - 6:02pm

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.

Key Points: 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Details of the transaction are in the document attached.